Wegener's granulomatosis.
To manage Wegener's granulomatosis (WG) effectively, the clinician must establish the diagnosis without delay, recognize variability in clinical course and severity, critically monitor disease activity, and anticipate disease-related and treatment-related morbidity. These issues represent the focus of approach to the diagnosis and treatment of WG.
Duna
G F
GF
Cleveland Clinic Foundation, Ohio, USA.
Galperin
C
C
Hoffman
G S
GS
D000970:Antineoplastic Agents / Q000627:therapeutic use; D001706:Biopsy; D014890:Granulomatosis with Polyangiitis / Q000175:diagnosis / Q000473:pathology / Q000628:therapy; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D007167:Immunotherapy; D015995:Prevalence; D014057:Tomography, X-Ray Computed
D000970:Antineoplastic Agents; D007166:Immunosuppressive Agents